West Pharmaceutical Services (WST) Gross Margin (2009 - 2026)
West Pharmaceutical Services (WST) posted quarterly Gross Margin of 37.74% for Q2 2026, up 201.0% year-on-year from 12.54% in Q2 2025, and up 7.58% on a QoQ basis from 35.08% in Q1 2026.
West Pharmaceutical Services (WST) Gross Margin (2009 - 2026) Analysis & Trends
West Pharmaceutical Services (WST) has reported Gross Margin for 18 consecutive years, with 37.74% the latest figure, recorded in Q2 2026.
- Quarterly Gross Margin rose 201.0% year-over-year to 37.74% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 36.79% (up 151.0% YoY) and the FY2025 annual result came in at 35.91%, up 140.0% from the prior year.
- Gross Margin improved to 37.74% in Q2 2026 per WST's latest filing, from 35.08% in the prior quarter.
- Over the last five years, Gross Margin for WST reached as high as 41.68% in Q2 2022 and fell as low as 32.76% in Q2 2024.
- A 5-year average of 36.9% and a median of 37.36% in 2026 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin sank 590 bps — and 2025, when it surged 297 bps.
- Year by year, Gross Margin stood at 36.98% in 2022, then climbed by 3 bps to 38.01% in 2023, then dropped by 4 bps to 36.54% in 2024, then gained by 3 bps to 37.75% in 2025, then fell by 0 bps to 37.74% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 37.74%, 35.08%, and 37.75% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 56.80% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 67.78% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 45.69% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 25.04% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 62.25% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 37.74% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 68.00% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 54.66% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 70.82% |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 32.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.74% |
| Mar 31, 2026 | 35.08% |
| Dec 31, 2025 | 37.75% |
| Sep 30, 2025 | 36.58% |
| Jun 30, 2025 | 35.73% |
| Mar 31, 2025 | 33.22% |
| Dec 31, 2024 | 36.54% |
| Sep 30, 2024 | 35.44% |
| Jun 30, 2024 | 32.76% |
| Mar 31, 2024 | 33.10% |
| Dec 31, 2023 | 38.01% |
| Sep 30, 2023 | 38.57% |
| Jun 30, 2023 | 38.66% |
| Mar 31, 2023 | 37.86% |
| Dec 31, 2022 | 36.98% |
| Sep 30, 2022 | 39.02% |
| Jun 30, 2022 | 41.68% |
| Mar 31, 2022 | 39.53% |
| Dec 31, 2021 | 41.13% |
| Sep 30, 2021 | 40.79% |